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Abstract  Patients  with  Graves’  ophthalmopathy  can  be  very  challenging  to  manage  secondary
to the  complex  nature  of  their  disease  presentation.  Patients  may  present  with  a  variety  of
ocular ﬁndings  including:  lid  retraction,  periorbital  and  lid  swelling,  chemosis,  conjunctival
hyperemia,  proptosis,  optic  neuropathy,  restrictive  myopathy,  exposure  keratopathy  and/or
keratoconjunctivitis  sicca.  Mini-scleral  and  scleral  lens  designs  have  been  important  in  the
management  of  irregular  and  regular  corneas,  and  in  the  therapy  of  ocular  surface  diseases.
We present  here  the  case  of  a  48-year-old  Caucasian  male  who  had  been  diagnosed  with
Graves’ ophthalmopathy  13  years  earlier.  With  signiﬁcant  ocular  surface  staining  and  over  ten
diopters of  astigmatism,  the  patient  had  never  been  able  to  wear  contact  lenses  comfortably.
After being  ﬁt  with  the  Mini-Scleral  DesignTM lenses,  his  vision  improved  to  20/25  OU,  his  ocular
surface improved,  and  overall  quality  of  vision  increased.
© 2012  Spanish  General  Council  of  Optometry.  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
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Uso  terapéutico  de  lentes  mini  esclerales  en  un  paciente  con  Oftalmopatía  de  Graves
Resumen  Puede  ser  difícil  tratar  a  los  pacientes  con  Oftalmopatía  de  Graves,  debido  a  la
naturaleza  compleja  de  la  presentación  de  su  enfermedad.  Los  pacientes  pueden  presentar
variedad de  manifestaciones  oculares  tales  como:  retracción  parpebral,  hinchazón  periorbital  y
parpebral,  quemosis,  hiperemia  conjuntival,  proptosis,  neuropatía  óptica,  miopatía  restrictiva,
queratopatía  por  exposición  y/o  queratoconjuntivitis  seca.  Los  disen˜os  de  lentes  mini  esclerales ser  importantes  para  el  tratamiento  de  las  córneas  irregulares  yy esclerales  han  resultado
regulares,  y  para  la  terapia  de  las  enfermedades  de  la  superﬁcie  ocular.
Presentamos  el  caso  de  un  varón  caucásico  de  cuarenta  y  ocho  an˜os  al  que  se  había
diagnosticado  Oftalmopatía  de  Graves  trece  an˜os  antes.  Con  una  signiﬁcativa  tinción  de  la
superﬁcie ocular,  y  más  de  diez  dioptrías  de  astigmatismo,  el  paciente  no  había  podido  llevar
nunca lentes  de  contacto  con  comodidad.  Tras  adaptarle  las  lentes  Mini-Scleral  DesignTM,  su
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visión  pasó  a  ser  de  20/25  OU,  mejorando  su  superﬁcie  ocular  e  incrementando  su  calidad  de
visión general.
©  2012  Spanish  General  Council  of  Optometry.  Publicado  por  Elsevier  España,  S.L.  Todos  los
derechos reservados.
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sIntroduction
Graves’  disease  is  an  autoimmune  disorder  that  is  most
commonly  known  as  hyperthyroidism.  This  disease  is
deﬁned  by  increased  thyroid  gland  synthesis  and  pro-
duction  of  the  thyroid  hormone.1 Manifestations  of  the
disease  are  thought  to  be  caused  by  production  of
antibodies  that  bind  to  the  thyroid-stimulating  hormone
receptor  (TSHR)  and  therefore  result  in  an  overproduc-
tion  of  the  T3  and  T4  hormones.2 While  patients  with
Graves’  disease  often  present  with  fatigue,  weakness,
heat  intolerance,  weight  loss,  tachycardia,  and  tremor,
they  may  also  present  with  ophthalmopathy;  one  of  the
main  and  potentially  serious  clinical  features.  Characteris-
tic  ocular  ﬁndings  include  lid  retraction,  lid  lag,  proptosis,
restrictive  extraocular  myopathy,  optic  neuropathy  and
inﬂammation  of  the  ocular  surface.2,3 Around  1/2000  women
per  year  are  affected  by  Graves’  and  it  occurs  5--10
times  lower  in  men,  with  peak  onset  at  40--60  years  of
age.1 Approximately  60%  of  patients  with  Graves’  dis-
ease  develop  Graves’  ophthalmopathy  and  85%  of  patients
with  Graves’  ophthalmopathy  present  with  ocular  surface
disease.2
Patients  with  Graves’  ophthalmopathy  will  typically
present  with  advanced  ocular  surface  disruption  which  can
lead  to  corneal  complications  and  irregularities.4 Patients
with  these  problems  who  also  require  refractive  correction
may  experience  difﬁculties  in  achieving  both  acceptable
quality  of  vision  and  improvement  in  their  ocular  surface
with  traditional  contact  lens  designs.  Although  smaller  diam-
eter  lenses  work  well  for  many  patients,  they  are  somewhat
limited  in  their  tear  reservoir  capacity,  whereas  mini-scleral
and  ultimately  scleral  contact  lenses  can  produce  a  much
larger  tear  reservoir,  reducing  mechanical  disruption  to  the
ocular  surface.  When  the  cornea  becomes  more  irregular,
the  ﬁtting  process  becomes  more  complex.  A  scleral  lens
may  be  indicated  for  the  irregular  cornea  to  create  a
smoother  refractive  surface  and  to  avoid  pressure  to  the
corneal  apex,  thus  minimizing  scarring.  Even  with  maxi-
mum  topical  and  systemic  therapy,  these  patients’  ocular
conditions  may  be  difﬁcult  to  manage.  With  the  option  of
mini-scleral  and  scleral  lens  designs,  patients  now  have
an  option  to  protect  the  cornea  and  offer  better  vision.
Scleral  contact  lenses  allow  for  successful  and  comfort-
able  ﬁtting  and  vision  in  patients  with  complex  corneas.
These  lenses  also  serve  as  a  pre-corneal  ﬂuid  reservoir
which  provides  optical  correction  while  rehabilitating  the
ocular  surface.5--7 The  following  case  involves  a  patient
with  Graves’  disease,  severe  ocular  surface  disruption,
and  keratoconus.  Secondary  to  his  irregular  astigmatism
and  ocular  surface  disease,  the  patient  was  ﬁt  with  mini-
scleral  lenses  not  only  to  assist  in  the  rehabilitation  of
his  ocular  surface,  but  also  to  improve  the  quality  of  his
vision.
c
i
c
aase report
 48-year-old  Caucasian  male  initially  presented  with  com-
laints  of  blur  at  distance  and  near  with  his  current  hybrid
enses,  double  vision  at  the  end  of  the  day,  and  signiﬁcant
edness  and  irritation  that  did  not  improve  with  traditional
upportive  dry  eye  therapy.  The  patient  had  been  diagnosed
ith  Graves’  13  years  earlier  and  was  status-post  a  com-
lete  thyroidectomy.  He  was  being  monitored  closely  by  his
ndocrinologist.  The  patient  had  failed  with  all  other  lens
odalities  and  was  concerned  that  the  problems  with  his
ision  and  ocular  discomfort  would  interfere  with  his  ability
o  continue  working.
Entering  corrected  vision  with  his  hybrid  lenses  was  20/30
D  and  20/50  OS.  His  refraction  was  −5.50  −  4.50  ×  082,
0/80  OD  and  −11.00  −  3.00  ×  115,  20/200  OS.  Topogra-
hies  showed  irregular  astigmatism  that  was  greater  in
he  right  eye  than  the  left,  10.44  diopters  OD  and  3.57
iopters  OS  (Fig.  1A  and  B).  Topographies  also  revealed
orneal  ectasia  (keratoconus)  OU.  Upon  further  investiga-
ion  of  the  patient’s  ocular  history,  keratoconus  had  not
een  discussed  with  the  patient  in  previous  examinations.
o  evident  restriction  was  noted  upon  extra-ocular  motili-
ies,  even  though  the  patient  complained  of  slight  diplopia
t  the  end  of  the  day.  Mild  proptosis  was  noted  OU,  with  an
ncreased  vertical  ﬁssure  width  measured.  Marginal  Reﬂex
istance  1  was  6  mm  for  both  the  right  eye  and  left  eye.
arginal  Reﬂex  Distance  2  was  7  mm  for  the  right  eye  and
 mm  for  the  left  eye.  The  corneas  showed  2+  diffuse  sodium
uorescein  staining  and  the  conjunctiva  showed  3+  lissamine
reen  staining  (Fig.  2A  and  B).  Schirmer  scores  without  anes-
hetic  were  13  mm  OD  and  8  mm  OS.  The  patient  was  started
n  Restasis® (cyclosporine  ophthalmic  emulsion)  0.05%  BID,
otemax® (loteprednol  etabonate  ophthalmic  suspension)
.5%  BID,  preservative  free  artiﬁcial  tears  QID,  and  preserva-
ive  free  ointment  QHS  OU  to  improve  his  ocular  surface  and
ncrease  tear  production.  Intraocular  pressure  was  12  mmHg
D  and  14  mmHg  OS  by  Goldmann  applanation  tonometry.
ilated  fundus  examination  was  unremarkable.
Successful  use  of  scleral  lenses  in  the  management  of
cular  surface  disease  has  been  well  documented.5--7 After
eviewing  the  patient’s  initial  presentation,  we  wanted  to
egin  the  lens  ﬁtting  process  with  the  18.2  mm  Jupiter
eries  to  create  increased  surface  coverage  and  enhance  the
herapeutic  effect  of  the  lenses.  However,  after  lengthy  dis-
ussion  with  the  patient  and  the  fact  that  the  patient  did
ot  have  insurance  at  the  time  of  the  initial  contact  lens  ﬁt-
ing,  mini-scleral  lenses  were  selected  to  try  to  keep  costs
own  while  still  having  some  therapeutic  effect  to  the  ocular
urface.  The  15.8  mm  Mini-Scleral  DesignTM lenses  (Blan-
hard  Contact  Lenses  Inc)  were  selected  due  to  the  patient’s
rregular  astigmatism,  ocular  surface  disruption,  and  dis-
omfort  with  other  lens  modalities.  Mini-scleral  lenses  were
lso  chosen  to  provide  a  protective  barrier  between  the  lids
64  J.S.  Harthan
Figure  1  Topographies  of  the  right  and  left  eye  demonstrating  10.44  and  3.57  diopters  of  irregular  astigmatism.
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Table  2  Final  MSD  lenses  ordered  and  dispensed.
SAG  Power  OAD  VA  Periphery
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as  interleukin  (IL)-1, tumor  necrosis  factor  (TNF)-, and
matrix  metalloproteinase  (MMP)-9  have  been  detected  in
the  tear  ﬁlm  of  patients  with  dry  eye,  suggesting  a relation-
ship  between  the  ocular  surface  inﬂammation  and  dry  eye.Figure  2  Lissamine  green  and  sodium  ﬂuorescein  staining  of
the conjunctiva  and  cornea  pre-MSD  lens  ﬁt.
and  the  cornea  during  blinking  and  to  provide  continuous
corneal  hydration  with  the  tear  reservoir,  thus  assisting  in
healing  the  corneal  epithelium.  Following  the  ﬁtting  guide,
which  is  based  on  sagittal  height  instead  of  back  surface
radii,  initial  lenses  were  selected  (Table  1).  The  initial  lenses
selected  had  a  standard  proﬁle  curve.  Key  endpoints  to
look  for  when  assessing  the  lens  ﬁt  are:  central  alignment
to  central  clearance  or  vault,  limbal  vault,  and  conjunc-
tival  alignment  with  no  impingement  or  blanching.  These
are  important  factors  to  look  for  so  that  the  lens  may  cre-
ate  a  corneal  bathing  effect.  The  lenses  were  ordered  in
Boston  XO2  material  (Dk  141)  to  allow  for  maximum  oxygen
transmission.
With  this  ﬁrst  pair  of  lenses,  central  touch  was  noted
OD  >  OS,  with  excessive  limbal  clearance  in  the  mid-
peripheral  zone,  and  slight  scleral  impingement  after  about
20  min  of  settling.  The  left  lens  demonstrated  more  cen-
tral  vault  with  peripheral  impingement.  Although  the  ﬁrst
set  of  diagnostic  lenses  were  not  an  ideal  ﬁt,  the  patient
immediately  noted  improved  ocular  comfort,  and  a  signiﬁ-
cant  improvement  in  the  quality  of  his  vision.  With  the  ﬁrst
pair  of  diagnostic  lenses,  the  patient’s  vision  improved  to
20/25  OD  and  20/30  OS.
The  ﬁnal  lenses  were  ordered  with  an  increased  cen-
tral  vault  OU.  The  periphery  was  adjusted  to  decrease
conjunctival  impingement  OS  (Table  2).  With  these  adjust-
ments,  the  proﬁle  curve  was  also  adjusted  to  the  Increased-I
curve  to  provide  adequate  vault  in  the  midperipheral-
limbal  clearance  zone.  The  overall  pattern  demonstrated
increased  central  clearance,  adequate  limbal  clearance,
and  no  conjunctival  impingement  in  the  periphery.  The
Table  1  Initial  MSD  parameters.
SAG  Power  OAD  VA  OR
OD  450S  Plano  15.8  20/25−  −3.75DS
OS 450S  Plano  15.8  20/30  −4.75 F
gOD  480I  −2.00  15.8  20/25  Standard
OS 470I  −3.75  15.8  20/25  1  step  ﬂat
atient’s  comfort  level  increased,  and  the  cornea  had  less
taining  (Fig.  3A--D).  The  patient  was  instructed  to  increase
is  wear  time  to  six  to  eight  hours  of  wear  per  day  and  was
nstructed  on  the  proper  use  of  Clear  Care® Cleaning  and
isinfection  solution,  a  hydrogen  peroxide-based  solution.
e  was  also  instructed  to  ﬁll  the  lenses  with  non-preserved
aline  prior  to  lens  insertion.  The  patient’s  corneal  staining
mproved  from  2+  ﬂuorescein  staining  to  trace  staining  after
 weeks  of  wearing  the  mini-scleral  lenses.  The  patient  has
een  successfully  wearing  the  lenses  for  5  months  noting  an
ncrease  in  the  clarity  of  his  vision,  quality  of  his  vision,  and
n  improvement  in  ocular  comfort.  The  periphery  of  the  ﬁnal
eft  lens  has  been  modiﬁed  again  to  decrease  impingement
nd  improve  the  overall  ﬂuorescein  pattern.
iscussion
atients  with  Graves’  ophthalmopathy  may  have  severe  ocu-
ar  complications  resulting  in  decreased  vision  and  corneal
eformities  that  are  difﬁcult  to  correct  with  glasses  alone.
hile  the  exact  etiology  of  ocular  dryness  due  to  Graves’
phthalmopathy  remains  unclear,  several  studies  have  sug-
ested  that  the  increased  orbital  ﬁssure  width  and  elevated
ear  ﬁlm  osmolality  contribute  to  the  cause  of  the  dryness.4,8
ther  studies  have  proposed  that  the  dryness  is  due  to
mpairment  of  the  lacrimal  gland  from  T  cell  dependent
nﬂammation  and  increased  evaporation  of  the  tear  ﬁlm.
wo  metaplastic  inﬂammatory  changes  in  the  temporal
nterpalpebral  bulbar  conjunctiva  are  observed  in  Graves’
isease  patients  with  dry  eye.  Inﬂammatory  factors  suchigure  3  Final  MSD  lenses  of  the  right  and  left  eye.  Lissamine
reen and  sodium  ﬂuorescein  staining  post-MSD  ﬁt.
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Lens. 2007;33:111--113.6  
atients  with  Graves’  ophthalmopathy  frequently  require
cular  and  systemic  therapy.  Our  patient  was  on  both  topical
nd  systemic  therapy  for  the  management  of  his  condi-
ion,  but  still  struggled  with  ocular  discomfort  and  unstable
ision.
Our  patient  presented  with  both  keratoconus  and  ocu-
ar  surface  disease.  Secondary  to  the  complex  nature  of  his
resentation,  mini-scleral  lenses  were  selected  to  promote
n  increased  tear  reservoir  while  optimizing  his  vision.  The
ini-Scleral  DesignTM lens  by  Blanchard  Contact  Lenses  Inc,
s  a  reverse  geometry  lens  with  an  adjustable  proﬁle  curve.
he  lens  also  has  an  aspheric  front  surface,  a  thinner  proﬁle,
nd  high  oxygen  permeability  to  promote  improved  vision,
omfort  and  corneal  health.  The  ﬁtting  guide  for  the  MSD
ens  is  based  on  sagittal  depth  rather  than  on  base  curve  with
he  goal  of  vaulting  the  cornea  and  the  limbus;  providing  an
dequate  tear  reservoir  while  creating  a  smooth  refractive
urface.  The  peripheral  edge  zone  can  also  be  adjusted  for
aximal  scleral  alignment.  Available  in  a  variety  of  sagittal
epths  and  diameters  of  15.8  mm  or  18.0  mm,  these  lenses
ay  be  beneﬁcial  for  patients  with  ocular  surface  disease
nd  irregular  corneas.
Although  scleral  lenses  have  not  been  indicated  for  treat-
ent  of  ocular  surface  disease  in  patients  with  Graves’
phthalmopathy,  theses  lenses  might  allow  some  patients
ith  irregular  corneas  to  delay  more  aggressive  interven-
ion.  A  combination  of  dry  eye  therapy  with  these  lenses
llow  for  treatment  and  restoration  of  moisture  from  the
iquid  reservoir  behind  the  lens  to  the  cornea  to  prevent
urther  damage.
Clear  and  comfortable  vision  may  be  achieved  using
ini-scleral  or  scleral  gas  permeable  lenses.  These  lenses
an  contribute  to  the  management  of  dry  eye  by  allow-
ng  more  tear  reservoir  from  the  vaulting  of  the  lens  and
roviding  increased  comfort  due  to  the  larger  size.5--7,9--12
hese  lenses  also  provide  refractive  correction  for  the
rregular  and  regular  astigmatism.  The  tear  ﬁlm  reservoir
ccumulated  under  the  lens  provides  optical  assistance
or  clearer  vision.  Irregular  corneal  changes  from  ocu-
ar  surface  disruption  can  often  times  make  it  more
hallenging  to  ﬁt  with  regular  soft  contact  lenses.  The
arger  lens  designs  and  a  high  Dk  gas  permeable  mate-
ial  provide  much  success  in  the  treatment  of  those
ith  severe  corneal  disease  and  keratectasias.4--7 Larger
iameter  gas  permeable  contact  lenses  provide  protec-
ion  to  the  eye,  acting  as  a  barrier  for  insubstantial
orneas  against  inﬂamed  tissue  of  the  lids.9--12 The  size
f  these  lenses  also  improves  comfort  as  the  lid  mar-
in  interacts  with  the  surface  of  the  lens  rather  than
he  edge.  The  use  of  mini-scleral  and  scleral  contact
enses  has  become  a  major  indication  for  individuals
ho  not  only  need  a  refractive  correction  but  also  suf-
er  from  irregular  corneas  and  severe  ocular  surface
isease.5--7,9--12Successful  use  of  mini-scleral  and  scleral  lens
esigns  have  been  reported  in  the  management  of  ocu-
ar  surface  disease.9--12 However,  while  the  etiology  of
cular  surface  dryness  and  the  role  of  scleral  lenses  in
atients  with  Graves’  are  not  clear,  close  monitoring  of  these
atients  is  important  to  avoid  potential  complications.  As
ith  any  lens  ﬁt,  potential  complications  that  may  arise
nclude  corneal  hypoxia,  conjunctival  and  corneal  staining,J.S.  Harthan
eovascularization,  corneal  inﬁltrates  and  microbial  kerati-
is.  These  complications  can  be  avoided  with  proper  patient
election,  ﬁtting  techniques,  patient  education,  and  with
lose  observation.  A  few  case  reports  have  looked  at  the
se  of  scleral  lenses  on  an  extended  wear  basis  to  protect
he  ocular  surface.13 When  prescribing  these  lenses  as  either
aily  wear  or  as  for  any  ocular  surface  condition,  careful
onsideration  is  needed  to  weigh  the  potential  beneﬁts  and
isks.
onclusion
ini-scleral  and  scleral  lenses  may  be  an  option  for  patients
ith  ocular  surface  damage  and  high  amounts  of  astigmatism
o  optimize  comfort  and  vision  quickly.  In  these  patients  who
ave  been  diagnosed  with  severe  ocular  surface  disease,
cleral  lenses  may  be  considered  as  a  therapeutic  device  to
ssist  in  rehabilitating  the  ocular  surface  and  to  determine
heir  optimum  vision  potential.  In  this  case,  a mini-scleral
ens  design  provided  improvement  in  the  patient’s  ocular
urface,  comfort  and  vision.  However,  further  investiga-
ion  is  needed  regarding  the  role  of  scleral  lens  designs  in
atients  with  Graves’  Ophthalmopathy.
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